HER2/EGFR in Cancer Research
This is a sourced subject-directory page. Its presence does not mean a factual answer has been researched, or that the subject is a proven knowledge gap.
Scope of this subject
This cluster of papers focuses on the use of HER2-targeted therapies, such as trastuzumab and pertuzumab, in the treatment of HER2-positive breast cancer. It explores the mechanisms of action, resistance, and combination therapies involving chemotherapy and monoclonal antibodies. The cluster also delves into the role of EGFR, neuregulin 1, and ADAM metalloproteinases in HER2 signaling and breast cancer progression.
OpenAlex generated this cluster description with an LLM. It describes research grouping, not verified findings.
Follow the subject hierarchy
Research vocabulary
HER2-positive breast cancer; trastuzumab; HER2; epidermal growth factor receptor; HER2-targeted therapy; HER2 amplification; HER3; pertuzumab; ERBB2; HER2 overexpression; HER2/neu; lapatinib; trastuzumab resistance; trastuzumab emtansine; trastuzumab deruxtecan; c-erbB-2; EGF receptor; ErbB receptors; ErbB4; HER2 expression; HER2-low breast cancer; HER2-positive metastatic breast cancer; neratinib; HER2 testing; BT474 cells
Current OpenAlex keyword associations; absence of a keyword does not establish absent knowledge.
Find the underlying research
OpenAlex topic record · Works associated with this topic
These external lists help locate papers. Assess the paper, date, method and limitations before using it as evidence. This service does not fetch submitted URLs.
Local answer status
No owner-reviewed answer has been published for this exact subject page. This is a gap in this collection; it does not establish that the answer is unavailable elsewhere.
Numeric address and provenance
Morton address: 36240728963310058 · morton4x16-v1
Coordinates: (4, 27, 2730, 10755). The address interleaves categorical identifier bits. Nearby addresses are not guaranteed to describe semantically similar subjects.
Structured subject record · Markdown · Source snapshots and licenses
What could you not find?
Submit the specific question you still need answered. This creates a private research request for owner review; it does not declare a scientific discovery or automatically generate an answer.